0 Комментарии
0 Поделились
257 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Статьи пользователей
-
Offers
-
Jobs
-
Courses
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Microbiome-Based Therapeutics Market Forecast: Industry Size, Share, and Future Trends"Global Executive Summary Microbiome-Based Therapeutics Market: Size, Share, and Forecast The global Microbiome-Based Therapeutics market size was valued at USD 3.17 billion in 2024 and is expected to reach USD 18.29 billion by 2032, at a CAGR of 24.50% during the forecast period This Microbiome-Based Therapeutics Market research report contains specific...0 Комментарии 0 Поделились 262 Просмотры 0 предпросмотр
-
Nucleic Acid-Based Therapeutics Market Outlook: Growth Trends & Market Opportunities"Executive Summary Nucleic Acid-Based Therapeutics Market Size and Share Analysis Report The global nucleic acid-based therapeutics market size was valued at USD 4.94 billion in 2024 and is expected to reach USD 14.38 billion by 2032, at a CAGR of 14.29% during the forecast period This Nucleic Acid-Based Therapeutics Market report is useful in evaluating...0 Комментарии 0 Поделились 247 Просмотры 0 предпросмотр
-
Adult Malignant Glioma Therapeutics Market Graph: Growth, Share, Value, Insights, and Trends1. Introduction Adult malignant gliomas are among the most aggressive and lethal cancers of the central nervous system. Originating in the glial cells of the brain, these tumors are characterized by rapid progression, high recurrence rates, and limited long-term survival outcomes. The most common and severe type, glioblastoma multiforme (GBM), remains extremely challenging to treat, despite...0 Комментарии 0 Поделились 866 Просмотры 0 предпросмотр
-
Adult Malignant Glioma Therapeutics Market Growth Drivers: Share, Value, Size, and Insights"Executive Summary Adult Malignant Glioma Therapeutics Market Research: Share and Size Intelligence Global adult malignant glioma therapeutics market size was valued at USD 2.63 billion in 2024 and is projected to reach USD 5.43 billion by 2032, with a CAGR of 9.50% during the forecast period of 2025 to 2032. Adult Malignant Glioma Therapeutics Market report makes available the...0 Комментарии 0 Поделились 803 Просмотры 0 предпросмотр
-
Adult Malignant Glioma Therapeutics Market Industry Statistics: Growth, Share, Value, Insights, and Trends"Market Trends Shaping Executive Summary Adult Malignant Glioma Therapeutics Market Size and Share Global adult malignant glioma therapeutics market size was valued at USD 2.63 billion in 2024 and is projected to reach USD 5.43 billion by 2032, with a CAGR of 9.50% during the forecast period of 2025 to 2032. Adult Malignant Glioma Therapeutics Market report performs geographical...0 Комментарии 0 Поделились 578 Просмотры 0 предпросмотр
-
Adult Malignant Glioma Therapeutics Market Scope: Growth, Share, Value, Size, and Trends"Executive Summary Adult Malignant Glioma Therapeutics Market Market Size and Share Across Top Segments CAGR Value Global adult malignant glioma therapeutics market size was valued at USD 2.63 billion in 2024 and is projected to reach USD 5.43 billion by 2032, with a CAGR of 9.50% during the forecast period of 2025 to 2032. Adult Malignant Glioma Therapeutics Market Market report has...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Adult Malignant Glioma Therapeutics Market: Comprehensive Analysis and Future OutlookIntroduction Adult malignant glioma represents one of the most aggressive and lethal forms of primary brain tumors, posing a significant clinical and economic burden worldwide. Characterized by rapid progression, invasive growth, and limited responsiveness to conventional therapies, malignant gliomas—particularly glioblastoma—continue to challenge oncologists and neuroscientists...0 Комментарии 0 Поделились 683 Просмотры 0 предпросмотр
-
Advance Renal Cell Carcinoma Therapeutics Market Growth, Revenue Analysis Industry Outlook, ForecastAnalysis By FMINEWARK, Del., USA | April 16, 2026 — According to the latest insights by Future Market Insights, the global advance renal cell carcinoma therapeutics market is entering a steady growth trajectory as oncology treatment paradigms evolve toward combination regimens. The market is valued at USD 7.80 billion in 2026 and is projected to reach USD 13.20 billion by 2036, expanding at a CAGR of...0 Комментарии 0 Поделились 41 Просмотры 0 предпросмотр
-
Advance Renal Cell Carcinoma Therapeutics Market Growth, Revenue, Key Factors, Major Companies, Forecast Analysis By FMINEWARK, Del., USA | April 16, 2026 — According to the latest insights by Future Market Insights, the global advance renal cell carcinoma therapeutics market is entering a steady growth trajectory as oncology treatment paradigms evolve toward combination regimens. The market is valued at USD 7.80 billion in 2026 and is projected to reach USD 13.20 billion by 2036, expanding at a CAGR of...0 Комментарии 0 Поделились 45 Просмотры 0 предпросмотр
-
Anti-Tuberculosis Therapeutics Market Size, Trends, Growth and Forecast 2025-2033Market OverviewThe global anti-tuberculosis therapeutics market size reached USD 1,530.1 Million in 2024. Forecasts indicate expansion to USD 2,552.2 Million by 2033, reflecting a CAGR of 5.56% during 2025-2033. This growth is driven by increasing healthcare expenditure, favorable reimbursement policies, technological progress, and expanding public-private partnerships. Anti-tuberculosis...0 Комментарии 0 Поделились 759 Просмотры 0 предпросмотр
-
Aptamers Market Gains Traction with Breakthroughs in Targeted Therapeutics"Future of Executive Summary Aptamers Market: Size and Share Dynamics CAGR Value The global aptamers market size was valued at USD 233.90 million in 2024 and is expected to reach USD 1016.52 million by 2032, at a CAGR of 20.16% during the forecast period The Aptamers Market report offers an analytical assessment of the prime challenges faced by the Aptamers...0 Комментарии 0 Поделились 76 Просмотры 0 предпросмотр
-
Anti-Cancer Drug Market Companies: Growth, Share, Value, Size, and Insights"Executive Summary Anti-Cancer Drug Market: Share, Size & Strategic Insights Data Bridge Market Research analyses that the global anti-cancer drug market which was USD 1,20,000.00 million in 2022, would rocket up to USD 2,97,000.00 million by 2030, and is expected to undergo a CAGR of 12.0% during the forecast period. The Anti-Cancer Drug report provides CAGR values along with its...0 Комментарии 0 Поделились 4Кб Просмотры 0 предпросмотр
Расширенные страницы
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek